Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab for Sick Leave Reduction in Early RA
NCT01405326Phase 4Unknown
- Sponsor
- Helsingin Reumakeskus
- Start
- May 2011
- Primary completion
- Dec 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in rheumatoid arthritis (RA), sponsored by Helsingin Reumakeskus. Status: unknown.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01405326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01405326.